Skip to main content
Equibles

HESTERBIO · Hester Biosciences Limited · Financials

Use HESTERBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HESTERBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2,343.65 INR +10.20 (+0.44%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 105 Avg daily vol (3M) 308

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
3.33B +6.9%
FY2026 Revenue FY2020–FY2026
Net Income
556.39M +102.4%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
641.41M -0.6%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 3.53B 3.33B 3.11B 3.05B 2.66B 2.35B 2.14B 1.83B
INR 244.66M 188.81M 168.02M 171.74M 206.95M 165.81M 133.14M 130.72M
INR 129.82M 109.34M 127.03M 197.75M 93.2M 40.64M 66.04M 73.7M
INR — — — — — — 501.03M 413.26M
INR 235.29M 183.52M 107.45M 107.87M 121.19M 140.18M 154.05M 103.24M
INR 1.42B 556.39M 274.88M 188.89M 266.27M 393.2M 344.3M 291.71M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 350.13M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.